NICE guidance on AFP for Hepatocellular Carcinoma
National Institute for Health and Care Excellence (NICE) is inviting experts to contribute to work exploring the use of AFP in the context of Hepatocellular Carcinoma. This is opportunity helps shape guidance that influence clinical practice, patient pathways and service delivery across the NHS.
Input from specialists will be key in ensuring that any recommendations support clinical benefit and promote the effective use of NHS resources for patients, carers, professionals and commissioners.
Please visit the NICE website to learn more and contribute to the consultation.